시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 공간 유전체학 및 전사체학 시장 보고서(2025년)
Spatial Genomics And Transcriptomics Global Market Report 2025
상품코드 : 1760719
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 175 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,482,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,370,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 12,257,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

공간유전체학 및 전사체학 시장 규모는 향후 몇 년 동안 연평균 12.4%의 성장률을 기록하며 2029년에는 27억 2,000만 달러 규모로 성장할 것으로 예측됩니다. 예측 기간 동안 예상되는 성장의 원동력은 질병의 조기 발견에 대한 수요 증가, 바이오마커 탐색 증가, 첨단 진단 의약품에 대한 규제 당국의 지원, 맞춤형 의료의 채택 확대, 암 연구의 지속적인 확대 등으로 인해 발생할 것으로 예측됩니다. 이 기간 동안 예상되는 주요 동향으로는 시퀀싱 기술의 향상, AI와 머신러닝의 통합, 혁신적인 데이터 처리 및 시각화 도구의 개발, 데이터 저장 및 분석 솔루션의 발전, 공동 연구 및 컨소시엄 증가 등이 있습니다.

맞춤형 의료의 채택 확대가 향후 몇 년간 공간유전체학 및 전사체학 시장의 성장을 가속할 것으로 예측됩니다. 맞춤의료는 유전적 체질, 생활습관, 환경적 요인에 따라 환자 개개인에 맞는 치료 계획을 수립하여 치료 효과를 높이고 부작용을 최소화하는 헬스케어 접근법입니다. 맞춤형 의료에 대한 수요 증가는 유전자 연구의 발전에 힘입은 바 큽니다. 유전자 연구의 발전으로 개인별 유전자 프로파일에 따라 맞춤형으로 보다 정밀한 치료가 가능해져 환자의 예후를 개선할 수 있게 되었습니다. 조직 내 유전자의 정확한 위치와 활성을 파악하는 것은 맞춤형 의료에서 중요한 역할을 합니다. 예를 들어, 2024년 2월 미국 비영리단체인 맞춤형 의료연합(Personalized Medicine Coalition)은 2023년 FDA가 희귀질환 환자를 위한 16개의 새로운 개인맞춤형 치료제를 승인했다고 보고했습니다. 그 결과, 맞춤형 의료의 채택이 증가하면서 공간유전체학 및 전사체학 시장의 성장을 견인하고 있습니다.

공간 유전체학 및 전사체학 시장의 주요 기업들은 조직 구조의 맥락에서 유전자 발현에 대한 이해를 높이기 위해 공간 전사체학 기술과 같은 혁신적인 솔루션 개발에 주력하고 있습니다. 공간 전사체학은 조직 샘플 전체의 유전자 발현을 공간적 맥락을 유지하면서 매핑하는 첨단 기술로, 연구자들은 조직 내 RNA 분자의 분포와 위치를 조사할 수 있습니다. 예를 들어, 2025년 2월 미국의 생명공학 기업 일루미나(Illumina)는 복잡한 조직 내 유전자 발현을 세포 해상도로 매핑하고 분석하는 능력을 크게 향상시키는 선구적인 공간적 전사체 기술을 발표했습니다. 이 기술은 기존 방법보다 9배 더 넓은 캡처 영역과 4배 더 높은 해상도를 제공하여 고감도, 편향성 없는 전체 전사체 프로파일링을 가능하게 합니다. Illumina NextSeq 및 NovaSeq 시퀀서와 호환되며, Illumina Connected Multiomics 플랫폼에 통합되어 종합적인 멀티오믹스 데이터 분석이 용이합니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 그리고 코로나재난과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장 잠재력이 높은 국가, 부문, 전략

제36장 부록

LSH
영문 목차

영문목차

Spatial genomics and transcriptomics encompass techniques that map the spatial distribution of gene expression and genetic information within tissues, enabling researchers to examine how cells interact within their native environments and contribute to biological processes or diseases. These methods offer high-resolution insights into gene activity at specific tissue locations, revealing cellular heterogeneity, disease mechanisms, and potential therapeutic targets.

The primary product types in spatial genomics and transcriptomics include instruments, consumables, and software. Instruments are devices or tools used for scientific research, including the investigation of natural phenomena and theoretical studies. These tools incorporate technologies such as spatial transcriptomics, sequencing-based methods, immunohistochemistry (IHC), microscopy-based RNA imaging techniques, and spatial genomics. They are applied in diagnostics, translational research, drug discovery and development, single-cell analysis, cell biology, and more. The main end users include pharmaceutical and biotechnology companies, contract research organizations, and academic and research institutes.

The spatial genomics and transcriptomics market research report is one of a series of new reports from The Business Research Company that provides spatial genomics and transcriptomics market statistics, including spatial genomics and transcriptomics industry global market size, regional shares, competitors with a spatial genomics and transcriptomics market share, detailed spatial genomics and transcriptomics market segments, market trends and opportunities, and any further data you may need to thrive in the spatial genomics and transcriptomics industry. This spatial genomics and transcriptomics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The spatial genomics and transcriptomics market size has grown rapidly in recent years. It will grow from $1.51 billion in 2024 to $1.70 billion in 2025 at a compound annual growth rate (CAGR) of 12.7%. The growth during the historic period can be attributed to the emergence of single-cell genomics, increased funding for cancer research, expansion of bioinformatics infrastructure, rising demand for precision medicine, and advancements in pharmaceutical research and development.

The spatial genomics and transcriptomics market size is expected to see rapid growth in the next few years. It will grow to $2.72 billion in 2029 at a compound annual growth rate (CAGR) of 12.4%. The anticipated growth in the forecast period is driven by the increasing need for early disease detection, a rise in biomarker discovery, regulatory support for advanced diagnostics, growing adoption of personalized medicine, and continued expansion in cancer research. Key trends expected during this period include improvements in sequencing technologies, integration of AI and machine learning, development of innovative data processing and visualization tools, advancements in data storage and analysis solutions, and increased collaborations and consortia.

The growing adoption of personalized medicine is expected to drive the growth of the spatial genomics and transcriptomics market in the coming years. Personalized medicine is an approach to healthcare that tailors treatment plans to individual patients based on their genetic makeup, lifestyle, and environmental factors, enhancing treatment effectiveness and minimizing side effects. The increasing demand for personalized medicine is fueled by advancements in genetic research, which enable more precise treatments customized to an individual's unique genetic profile, leading to improved patient outcomes. Spatial genomics and transcriptomics play a key role in personalized medicine by identifying the precise location and activity of genes within tissues, allowing for targeted, individualized treatment strategies based on a patient's molecular landscape. For example, in February 2024, the Personalized Medicine Coalition, a U.S.-based nonprofit organization, reported that the FDA approved 16 new personalized treatments for patients with rare diseases in 2023, a significant increase from the six approvals in 2022. As a result, the rising adoption of personalized medicine is driving the growth of the spatial genomics and transcriptomics market.

Leading companies in the spatial genomics and transcriptomics market are focusing on developing innovative solutions, such as spatial transcriptomics technologies, to deepen our understanding of gene expression in the context of tissue architecture. Spatial transcriptomics refers to advanced techniques that map gene expression across tissue samples while maintaining their spatial context, allowing researchers to study the distribution and location of RNA molecules within tissues. For instance, in February 2025, Illumina Inc., a U.S.-based biotechnology company, launched pioneering spatial transcriptomics technology that significantly enhances the ability to map and analyze gene expression within complex tissues at cellular resolution. This technology offers a capture area nine times larger and four times higher resolution than existing methods, enabling unbiased, whole-transcriptome profiling with high sensitivity. It is compatible with Illumina's NextSeq and NovaSeq sequencers and integrated into the Illumina Connected Multiomics platform, facilitating comprehensive multiomic data analysis.

In April 2024, Bruker Corporation, a U.S.-based manufacturer of scientific instruments and analytical solutions, acquired NanoString Technologies for an undisclosed amount. This acquisition aims to enhance Bruker's spatial biology portfolio by integrating NanoString's gene expression and spatial transcriptomics solutions. This move positions Bruker as a market leader, fostering innovation, revenue growth, and long-term value in the post-genomic era. NanoString Technologies is a U.S.-based biotechnology company specializing in spatial genomics and transcriptomics solutions.

Major players in the spatial genomics and transcriptomics market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., Bruker Corporation, Bio-Techne Corporation, 10x Genomics Inc., Standard BioTools Inc., Akoya Biosciences Inc., Seven Bridges Genomics, Vizgen Inc., Lunaphore Technologies SA., Parse Biosciences, Indica Labs Inc., Resolve Biosciences GmbH., RareCyte Inc., Ionpath Inc., Dovetail Genomics, S2 Genomics Inc., and BioSpyder Technologies Inc.

North America was the largest region in the spatial genomics and transcriptomics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in spatial genomics and transcriptomics report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the spatial genomics and transcriptomics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The spatial genomics and transcriptomics market includes revenues earned by entities by providing services such as spatial gene expression profiling, single-cell RNA sequencing, spatially resolved transcriptome analysis, cancer and disease research, and spatial epigenomics. The market value includes the value of related goods sold by the service provider or included within the service offering. The spatial genomics and transcriptomics market also includes sales of spatial transcriptomics platforms, imaging systems, and sequencing instruments. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Spatial Genomics And Transcriptomics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on spatial genomics and transcriptomics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for spatial genomics and transcriptomics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The spatial genomics and transcriptomics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Spatial Genomics And Transcriptomics Market Characteristics

3. Spatial Genomics And Transcriptomics Market Trends And Strategies

4. Spatial Genomics And Transcriptomics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Spatial Genomics And Transcriptomics Growth Analysis And Strategic Analysis Framework

6. Spatial Genomics And Transcriptomics Market Segmentation

7. Spatial Genomics And Transcriptomics Market Regional And Country Analysis

8. Asia-Pacific Spatial Genomics And Transcriptomics Market

9. China Spatial Genomics And Transcriptomics Market

10. India Spatial Genomics And Transcriptomics Market

11. Japan Spatial Genomics And Transcriptomics Market

12. Australia Spatial Genomics And Transcriptomics Market

13. Indonesia Spatial Genomics And Transcriptomics Market

14. South Korea Spatial Genomics And Transcriptomics Market

15. Western Europe Spatial Genomics And Transcriptomics Market

16. UK Spatial Genomics And Transcriptomics Market

17. Germany Spatial Genomics And Transcriptomics Market

18. France Spatial Genomics And Transcriptomics Market

19. Italy Spatial Genomics And Transcriptomics Market

20. Spain Spatial Genomics And Transcriptomics Market

21. Eastern Europe Spatial Genomics And Transcriptomics Market

22. Russia Spatial Genomics And Transcriptomics Market

23. North America Spatial Genomics And Transcriptomics Market

24. USA Spatial Genomics And Transcriptomics Market

25. Canada Spatial Genomics And Transcriptomics Market

26. South America Spatial Genomics And Transcriptomics Market

27. Brazil Spatial Genomics And Transcriptomics Market

28. Middle East Spatial Genomics And Transcriptomics Market

29. Africa Spatial Genomics And Transcriptomics Market

30. Spatial Genomics And Transcriptomics Market Competitive Landscape And Company Profiles

31. Spatial Genomics And Transcriptomics Market Other Major And Innovative Companies

32. Global Spatial Genomics And Transcriptomics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Spatial Genomics And Transcriptomics Market

34. Recent Developments In The Spatial Genomics And Transcriptomics Market

35. Spatial Genomics And Transcriptomics Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기